Home > Journals > Acta Vulnologica > Past Issues > Acta Vulnologica 2008 December;6(4) > Acta Vulnologica 2008 December;6(4):193-7






Acta Vulnologica 2008 December;6(4):193-7


language: Italian

Bioenginerezed cellulose Crystacell 77™ (Veloderm®) in the treatment of superficial skin lesions

Mancini S., Gazzabin L., Menchinelli M., Tommasino G., Cassioli V., Botta G., Mancini S.

Centro di Ricerca, Terapia e Riabilitazione Flebolinfologia Dipartimento di Chirurgia Università di Siena, Siena, Italia


Aim. In the Phlebo-lymphological Centre of the University of Siena the efficacy of Veloderm® (BTC srl, Ancona, Italia) in the treatment of superficial skin lesions in lower limbs was evaluate.
Methods. A total of 51 skin lesions, derived by traumatical injury (Group A – 38 lesions) like first dressing and in re-epithelization time (Group B – 13 lesions) of multiple etiopathogenesis were evaluated. Common characteristics were superficial thickness, scarce or absent exudate, neither infection nor inflammation. Lesion area was of 9.64 cm2 (range 0.25-128 cm2) in Group A, and 1.55 cm2 (range 0.25-3.8 cm2) in Group B. Veloderm® was applied with saline solution and covered with jaluronic gauze for preventing gauze injuries at the control and completed with a compression depending on clinical case. Controls were performed once a week.
Results. At first control Veloderm® was completely adherent to the lesion in 92.1% of cases (47/51 lesions), while in the other 4 cases a new dressing had to be applied. All lesion healed in both groups in a mean time of 21.78±15.27 SD days in Group A, and 19.15±5.55 SD days in Group B, within the first month of treatment and utilizing only one dressing in 100% of the cases in Group B and in 89.5% in Group A.
Conclusion. Veloderm® demonstrated to be an optimal dressing for the treatment of superficial skin lesion with low or absent exudate.

top of page